← Nurses CPD
Prostate Cancer Management: The Role of PET Imaging and Advanced Therapies
Please be informed that participation in the post-test assessment is mandatory for the issuance of certificates and the allocation of associated CPD points when finalized. Completion and passing of the post-test are required to validate your attendance and ensure compliance with CPD accreditation requirements for this session. Thank you for your cooperation and commitment to professional development.
PET Imaging & Targeted Therapies in Cancer: A Masterclass Series
SESSION FIVE: Prostate Cancer Management: The Role of PET Imaging and Advanced Therapies
This session delves into the pivotal role of PET imaging in the detection, staging, and management of prostate cancer. With a focus on enhancing diagnostic accuracy, PET scans provide critical insights into tumor biology, facilitating earlier detection and better assessment of disease progression. The session also explores advanced therapies in prostate cancer, including hormone therapy, targeted therapies, and immunotherapies, emphasizing how these treatments are optimized by PET imaging to improve patient outcomes. Led by experts in nuclear medicine and oncology, participants will gain comprehensive knowledge of how PET imaging is integrated into the clinical management of prostate cancer, with a focus on achieving personalized and effective treatment strategies.
The series consists of five specialized sessions, each focusing on a specific cancer type and addressing its unique challenges and innovations in care. Each session will be led by highly qualified and experienced facilitators in oncology and medical imaging, bringing together theoretical insights and practical applications in an interactive format. The series will incorporate Q&A sessions to encourage in-depth discussions and ensure that participants gain actionable knowledge to apply in clinical practice.
SESSION BREAKDOWN
Each individual topic in the series has been carefully crafted to build on the knowledge acquired in previous sessions while allowing participants to engage deeply with each aspect of PET imaging and targeted therapies in cancer. The topics include:
Session 1: The Significance of PET Scans in Oncology: A Cornerstone of Modern Cancer Care
Session 2: Enhancing Breast Cancer Management through PET Scans and Targeted Therapies
Session 3: PET Imaging and Targeted Therapies in Hematological Malignancies
Session 4: Lung Cancer Diagnosis and Treatment: The Impact of PET Imaging and Targeted Therapies
Session 5: Prostate Cancer Management: The Role of PET Imaging and Advanced Therapies
EARN CPD POINTS
Participants will earn valuable CPD points upon successful completion of each session, supporting their continuous professional development and helping them stay at the forefront of advancements in cancer care. This credentialing underscores the commitment of SGMC to foster professional growth and knowledge enhancement in the medical community, ensuring that participants are recognized for their dedication to advancing patient outcomes.
WHY REGISTER AND ATTEND THIS TRAINING SERIES?
This masterclass series offers a unique opportunity to learn from renowned experts and gain cutting-edge knowledge in the rapidly evolving field of cancer diagnostics and treatment. Whether you're an oncologist, radiologist, or healthcare professional interested in oncology, attending these sessions will provide you with practical insights and the latest research to elevate patient care. Participants will also benefit from an interactive format, engaging directly with facilitators and peers through thought-provoking discussions and Q&A sessions.
SESSION 3: PET Imaging and Targeted Therapies in Hematological Malignancies
This session focuses on the pivotal role of PET imaging in the diagnosis, staging, and treatment monitoring of hematological malignancies, including lymphoma and leukemia. Participants will gain insights into the integration of PET scans into clinical workflows, enhancing the accuracy of disease detection and therapeutic response evaluation. Additionally, the session explores advancements in targeted treatments for hematological cancers and how PET imaging aids in optimizing these therapies. Facilitated by leading experts, this interactive session is designed to empower participants with cutting-edge knowledge and practical strategies to enhance outcomes in hematological.
ORGANIZED BY
PROUDLY SPONSORED BY
This virtual training will premier on Thursday the 19th of December 2024 at 4:00 PM.
Target Audience: Medical Doctors, Pharmacists, Nurses and Radiotherapists
Moderator: Dr. Amankwaa Frempong
Date: Thursday 19th December 2024
Time: 16:00 GMT (4:00 pm local time)
AGENDA
Thursday 19th December 2024 (VIRTUAL EVENT)
Overview
Course Description
This session highlights the transformative role of PET imaging in the detection, staging, and management of prostate cancer, alongside its integration with advanced therapeutic strategies. Participants will explore the clinical utility of PET scans, particularly PSMA-targeted imaging, in identifying metastatic disease and guiding personalized treatment plans. Discussions will also focus on cutting-edge therapies, such as PSMA-targeted radionuclide therapy, and their synergistic use with PET imaging to optimize patient outcomes. Facilitated by experts in urology, this session aims to equip healthcare professionals with knowledge on leveraging advanced diagnostics and therapies to enhance prostate cancer care.
What you will learn
At the end of this session, participants will be able to:
1. Understand the role of PET imaging in the detection and staging of prostate cancer.
2. Comprehend the integration of PET scans in assessing disease progression and treatment efficacy in prostate cancer.
3. Explore the latest advanced therapies in prostate cancer treatment, including hormone therapy and immunotherapy.
4. Identify how PET imaging is utilized to optimize outcomes in advanced prostate cancer therapies.
5. Discuss the multidisciplinary approach to prostate cancer management with the inclusion of PET imaging in treatment planning and decision-making.
Course Content
Lecture Sessions
- LIVE EVENT: Thursday 19th December 2024 from 1600 GMT (4:00 pm) 2 hours
Downloadables
No downloadable content added to this course yet.
Steps to Join Course
About Facilitators
- 2 Courses on CES
Prof. James Edward Mensah
BSc, MB ChB, FGCS, FWACS
Senior Lecturer (SMD-UG), Head of Surgery Department (SMD-KBTH), Head of Urology Unit (KBTH)
School of Medicine and Dentistry, University of Ghana
Korle Bu Teaching Hospital
Prof. James Edward Mensah, a distinguished medical professional, currently holds the positions of Head of the Surgery Department and Head of the Urology Unit at the Korle Bu Teaching Hospital. Concurrently, he serves as a Senior Lecturer at the School of Medicine and Dentistry at the University of Ghana.
View full profile / courses
- 1 Course on CES
Dr. Kwaku Addai Arhin Appiah
BSc, MBChB, MPhil, MGCPS, FWACS
Senior Lecturer / Urologist
Kwame Nkrumah University of Science and Technology (KNUST) | Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana.
Dr. Kwaku Addai Arhin Appiah is a Senior Lecturer in the Department of Surgery, where he imparts knowledge in Principles of Surgery and Surgical Pathology, focusing on topics relevant to Ghana and the West African sub-region.
View full profile / coursesRelated Courses
